Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 241-247

  Khunamornpong, Surapan ^a   Settakorn, Jongkolnee ^a   Sukpan, Kornkanok ^a   Srisomboon, Jatupol ^a   Ruangvejvorachai, Preecha ^b   Thorner, Paul S ^c   Siriaunkgul, Sumalee ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cyclooxygenase 2; Lymph node metastasis; Lymphovascular space invasion; Squamous cell carcinoma; Uterine cervix

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DEEP STROMAL INVASION; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 57649088449     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.017     Document Type: Article

References (33)

1. Haffty B.G., Yang Q., Moran M.S., Tan A.R., and Reiss M. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation. Int. J. Radiat. Oncol. Biol. Phys. 71 (2008) 1006-1013
2. Han S.L., Tang H.J., Hua Y.W., Ji S.Q., and Lin D.X. Expression of COX-2 in stomach cancers and its relation to their biological features. Dig. Surg. 20 (2003) 107-114
3. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., and Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 58 (1998) 3761-3764
4. Khor L.Y., Bae K., Pollack A., Hammond M.E., Grignon D.J., Venkatesan V.M., Rosenthal S.A., Ritter M.A., Sandler H.M., Hanks G.E., Shipley W.U., and Dicker A.P. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncol. 8 (2007) 912-920
5. Kim H.S., Youm H.R., Lee J.S., Min K.W., Chung J.H., and Park C.S. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer. Lung Cancer 42 (2003) 163-170
6. Liu J.F., Jamieson G., Wu T.C., Zhang S.W., Wang Q.Z., and Drew P. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis. Esophagus 19 (2006) 350-354
7. Sheehan K.M., Sheahan K., O'Donoghue D.P., MacSweeney F., Conroy R.M., Fitzgerald D.J., and Murray F.E. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 282 (1999) 1254-1257
8. Soumaoro L.T., Uetake H., Higuchi T., Takagi Y., Enomoto M., and Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin. Cancer Res. 10 (2004) 8465-8471
9. Zhang X.H., Huang D.P., Guo G.L., Chen G.R., Zhang H.X., Wan L., and Chen S.Y. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 8 (2008) 4
10. Dursun P., Yuce K., Usubutun A., and Ayhan A. Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. Int. J. Gynecol. Cancer 17 (2007) 164-173
11. Ferrandina G., Legge F., Ranelletti F.O., Zannoni G.F., Maggiano N., Evangelisti A., Mancuso S., Scambia G., and Lauriola L. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer 95 (2002) 801-807
12. Kakiuchi Y., Tsuji S., Tsujii M., Murata H., Kawai N., Yasumaru M., Kimura A., Komori M., Irie T., Miyoshi E., Sasaki Y., Hayashi N., Kawano S., and Hori M. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res. 62 (2002) 1567-1572
13. Munkarah A., and Ali-Fehmi R. COX-2: a protein with an active role in gynecological cancers. Curr. Opin. Obstet. Gynecol. 17 (2005) 49-53
14. Kulkarni S., Rader J.S., Zhang F., Liapis H., Koki A.T., Masferrer J.L., Subbaramaiah K., and Dannenberg A.J. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin. Cancer Res. 7 (2001) 429-434
15. Ryu H.S., Chang K.H., Yang H.W., Kim M.S., Kwon H.C., and Oh K.S. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol. Oncol. 76 (2000) 320-325
16. Young J.L., Jazaeri A.A., Darus C.J., and Modesitt S.C. Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol. Oncol. 109 (2008) 140-145
17. Kim M.H., Seo S.S., Song Y.S., Kang D.H., Park I.A., Kang S.B., and Lee H.P. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol. Oncol. 90 (2003) 83-90
18. Manchana T., Triratanachat S., Sirisabya N., Vasuratna A., Termrungruanglert W., and Tresukosol D. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer. Gynecol. Oncol. 100 (2006) 556-560
19. Roman L.D., Felix J.C., Muderspach L.I., Varkey T., Burnett A.F., Qian D., and Morrow C.P. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol. Oncol. 68 (1998) 220-225
20. Gaffney D.K., Holden J., Zempolich K., Murphy K.J., Dicker A.P., and Dodson M. Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control. Am. J. Clin. Oncol. 24 (2001) 443-446
21. Chen Y.J., Wang L.S., Wang P.H., Lai C.R., Yen M.S., Ng H.T., and Yuan C.C. High cyclooxygenase-2 expression in cervical adenocarcinomas. Gynecol. Oncol. 88 (2003) 379-385
22. Kim H.J., Wu H.G., Park I.A., and Ha S.W. High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 16-20
23. Pyo H., Kim Y.B., Cho N.H., Suh C.O., Park T.K., Yun Y.S., and Kim G.E. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 725-732
24. Ferrandina G., Lauriola L., Distefano M.G., Zannoni G.F., Gessi M., Legge F., Maggiano N., Mancuso S., Capelli A., Scambia G., and Ranelletti F.O. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J. Clin. Oncol. 20 (2002) 973-981
25. Kim Y.B., Kim G.E., Cho N.H., Pyo H.R., Shim S.J., Chang S.K., Park H.C., Suh C.O., Park T.K., and Kim B.S. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 95 (2002) 531-539
26. Ferrandina G., Ranelletti F.O., Legge F., Lauriola L., Poerio A., Zannoni G.F., Smaniotto D., Margariti P.A., Macchia G., and Scambia G. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 21-27
27. Kim Y.B., Kim G.E., Pyo H.R., Cho N.H., Keum K.C., Lee C.G., Seong J., Suh C.O., and Park T.K. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 822-829
28. Baltazar F., Filho A.L., Pinheiro C., Moreira M.A., Queiroz G.S., Oton G.J., Junior A.F., Ribeiro L.F., and Schmitt F.C. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas. Int. J. Gynecol. Pathol. 26 (2007) 235-241
29. Vinh-Hung V., Bourgain C., Vlastos G., Cserni G., De Ridder M., Storme G., and Vlastos A.T. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 7 (2007) 164
30. Yao M., Lam E.C., Kelly C.R., Zhou W., and Wolfe M.M. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br. J. Cancer 90 (2004) 712-719
31. Yazawa K., Tsuno N.H., Kitayama J., Kawai K., Okaji Y., Asakage M., Sunami E., Kaisaki S., Hori N., Watanabe T., Takahashi K., and Nagawa H. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin. Cancer Sci. 96 (2005) 93-99
32. Ferrandina G., Ranelletti F.O., Lauriola L., Zannoni G.F., Legge F., Gessi M., Salutari V., and Scambia G. Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer. Oncol. Rep. 10 (2003) 1799-1804
33. Kim J.S., Li S., Kim J.M., Yeo S.G., Kim K.H., and Cho M.J. Cyclooxygenase-2 expression as a predictor of para-aortic lymph node recurrence in uterine cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 70 (2008) 1516-1521